Variable | All participants (n = 88) | Participants with mild impairment (n = 69) | Participants with moderate impairment (n = 19) | Significance |
---|---|---|---|---|
Age (years) | 57.27 (12.75) | 57.39 (11.59) | 56.84 (16.68) | p = .870 |
Sex (n, %) | p = .405 | |||
Women | 30 (34.1%) | 22 (31.9%) | 8 (42.1%) | |
Men | 58 (65.9%) | 47 (68.1%) | 11 (57.9%) | |
Time since injury (months) | 49.13 (59.68) | 46.15 (52.53) | 59.96 (47.82) | p = .375 |
Etiology (n, %) | p = .580 | |||
Ischemic | 46 (52.3%) | 35 (50.7%) | 11 (57.9%) | |
Hemorrhagic | 42 (47.7%) | 34 (49.3%) | 8 (42.1%) | |
Oxford classification (n, %) | p = .453 | |||
TACI | 3 (3.4%) | 2 (5.7%) | 1 (9.1%) | |
PACI | 29 (33.%) | 23 (65.7%) | 6 (54.5%) | |
LACI | 6 (6.8%) | 3 (8.6%) | 3 (27.3%) | |
POCI | 8 (9.1%) | 7 (20.0%) | 1 (9.1%) | |
Lesion side (n, %) | p = .892 | |||
Left | 47 (53.4%) | 36 (52.2%) | 11 (57.9%) | |
Right | 35 (39.8%) | 28 (40.6%) | 7 (36.8%) | |
Bilateral | 6 (6.8%) | 5 (7.2) | 1 (5.3%) | |
Fugl-Meyer Assessment for Upper Extremity | 53.02 (9.52) | 57.10 (5.28) | 38.21 (6.16) | p < .001 |